(Q37964498)

26 August 2017

The role of the kynurenine metabolism in major depression (English)

1 reference

26 August 2017

3

Norbert Müller

1 reference

26 August 2017

Aye-Mu Myint

1

1 reference

PubMed ID

22139324

26 August 2017

Markus J Schwarz

series ordinal

2

1 reference

PubMed ID

22139324

26 August 2017

language of work or name

1 reference

3 December 2011

1 reference

Journal of Neural Transmission

26 August 2017

1 reference

26 August 2017

119

1 reference

26 August 2017

2

1 reference

26 August 2017

245-251

1 reference

https://scigraph.springernature.com/pub.10.1007/s00702-011-0741-3

26 August 2017

0 references

cites work

Distinct pattern of microglial response, cyclooxygenase-2, and inducible nitric oxide synthase expression in the aged rat brain after excitotoxic damage

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Depression, stress and immunological activation: the role of cytokines in depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

COX1 and COX2 expression in non-neuronal cellular compartments of the rhesus macaque brain during lentiviral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Effects of the diet on brain neurotransmitters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

l-Kynurenine Its synthesis and possible regulatory function in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

IDO induction in IFN-gamma activated astroglia: a role in improving cell viability during oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Human microglia convert l-tryptophan into the neurotoxin quinolinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Psychiatric symptoms related to interferon therapy for chronic hepatitis C: clinical features and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Low natural killer cytotoxicity in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Quinolinate neurotoxicity in cortical cell culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Immune disorders in depression: higher T helper/T suppressor-cytotoxic cell ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Negative Immunoregulatory Effects of Antidepressants Inhibition of Interferon-γ and Stimulation of Interleukin-10 Secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Tryptophan and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Th1, Th2, and Th3 cytokine alterations in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Fluctuations in endogenous kynurenic acid control hippocampal glutamate and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

The role of tryptophan 2,3-dioxygenase in the hormonal control of tryptophan metabolism in isolated rat liver cells. Effects of glucocorticoids and experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Cytokines and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Indicators of immune activation in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

The macrophage theory of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Stereospecificity of hepatic L-tryptophan 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Interferon enhances tryptophan metabolism by inducing pulmonary indoleamine 2,3-dioxygenase: its possible occurrence in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Effect of albumin binding and amino acid competition on tryptophan uptake into brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Increase in Interleukin-1β in Late-Life Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

Kynurenine pathway in major depression: Evidence of impaired neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0741-3

The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications

21 January 2018

1 reference

12 December 2020

Cytokine production and treatment response in major depressive disorder

1 reference

12 December 2020

Quantitative aspects of tryptophan metabolism in humans and other species: a review

1 reference

12 December 2020

Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine

1 reference

12 December 2020

Two mechanisms which increase in vivo the liver tryptophan peroxidase activity: specific enzyme adaptation and stimulation of the pituitary adrenal system

1 reference

12 December 2020

The "kynurenine shunt" and depression.

1 reference

12 December 2020

The plasma levels of interleukin-12 in schizophrenia, major depression and bipolar mania: effects of psychotropic drugs

1 reference

12 December 2020

3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity.

1 reference

12 December 2020

Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes

1 reference

12 December 2020

Effects of a dietary excess of leucine and of the addition of leucine and 2-oxo-isocaproate on the metabolism of tryptophan and niacin in isolated rat liver cells

1 reference

12 December 2020

Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures

1 reference

12 December 2020

Platelet serotonin content and free and total plasma tryptophan in healthy volunteers during 24 hours

1 reference

12 December 2020

Differential effects of kynurenine and tryptophan treatment on quinolinate immunoreactivity in rat lymphoid and non-lymphoid organs

1 reference

12 December 2020

Isoform-specific effects of apolipoprotein E on secretion of inflammatory mediators in adult rat microglia

1 reference

12 December 2020

Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining

1 reference

12 December 2020

Murine glial cells regenerate NAD, after peroxide-induced depletion, using either nicotinic acid, nicotinamide, or quinolinic acid as substrates

1 reference

12 December 2020

Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

1 reference

12 December 2020

Cytokines in major depression

1 reference

12 December 2020

Major depression and immunity: preliminary evidence of decreased natural killer cell populations

1 reference

12 December 2020

Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features

1 reference

12 December 2020

[Synthesis and resolution of chiral ring-opened serotonin analogs of the 5-hydroxykynuramine type]

1 reference

12 December 2020

10.1007/S00702-011-0741-3

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22139324